1989 …2018

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Barbara Gamberi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 41 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials

D'Agostino, M., De Paoli, L., Conticello, C., Offidani, M., Ria, R., Petrucci, M. T., Spada, S., Marcatti, M., Catalano, L., Gilestro, M., Guglielmelli, T., Baldini, L., Gamberi, B., Rizzi, R., De Sabbata, G., Di Renzo, N., Patriarca, F., Pezzatti, S., Siniscalchi, A., Ribolla, R. & 5 others, Palumbo, A., Montefusco, V., Nagler, A., Boccadoro, M. & Gay, F., Dec 2018, In : Critical Reviews in Oncology/Hematology. 132, p. 9-16 8 p.

Research output: Contribution to journalReview article

  • Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials

    D'Agostino, M., De Paoli, L., Conticello, C., Offidani, M., Ria, R., Petrucci, M. T., Spada, S., Marcatti, M., Catalano, L., Gilestro, M., Guglielmelli, T., Baldini, L., Gamberi, B., Rizzi, R., De Sabbata, G., Di Renzo, N., Patriarca, F., Pezzatti, S., Siniscalchi, A., Ribolla, R. & 5 others, Palumbo, A., Montefusco, V., Nagler, A., Boccadoro, M. & Gay, F., Dec 1 2018, In : Critical Reviews in Oncology/Hematology. 132, p. 9-16 8 p.

    Research output: Contribution to journalReview article

  • Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials

    D'Agostino, M., De Paoli, L., Conticello, C., Offidani, M., Ria, R., Petrucci, M. T., Spada, S., Marcatti, M., Catalano, L., Gilestro, M., Guglielmelli, T., Baldini, L., Gamberi, B., Rizzi, R., De Sabbata, G., Di Renzo, N., Patriarca, F., Pezzatti, S., Siniscalchi, A., Ribolla, R. & 5 others, Palumbo, A., Montefusco, V., Nagler, A., Boccadoro, M. & Gay, F., 2018, In : Critical Reviews in Oncology/Hematology. 132, p. 9-16 8 p.

    Research output: Contribution to journalArticle

    Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis

    Gambella, M., Omedé, P., Spada, S., Muccio, V. E., Gilestro, M., Saraci, E., Grammatico, S., Larocca, A., Conticello, C., Bernardini, A., Gamberi, B., Troia, R., Liberati, A. M., Offidani, M., Rocci, A., Palumbo, A., Cavo, M., Sonneveld, P., Boccadoro, M. & Oliva, S., Jan 1 2018, (Accepted/In press) In : Cancer.

    Research output: Contribution to journalArticle

  • Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and renal impairment: Results from a phase ii trial

    Dimopoulos, M., Weisel, K., van de Donk, N. W. C. J., Ramasamy, K., Gamberi, B., Streetly, M., Offidani, M., Bridoux, F., de la Rubia, J., Mateos, M. V., Ardizzoia, A., Kueenburg, E., Collins, S., Di Micco, A., Rosettani, B., Li, Y., Bacon, P. & Sonneveld, P., Jul 10 2018, In : Journal of Clinical Oncology. 36, 20, p. 2035-2043 9 p.

    Research output: Contribution to journalArticle